(All fields required)
Please enter a valid email.
Please enter your name.
Cincinnati Children’s is the acknowledged leader in treating and studying eosinophilic disorders. Private donors played a key role in advancing the research.
David Franz, MD, launched a clinic for patients with tuberous sclerosis in 1992. Today our TS program is the world’s largest and a pioneer in clinical research.
Antonio was able to play outdoors last summer because his asthma is under control, thanks to an education and support initiative at Cincinnati Children’s.
The Convalescent Hospital for Children has continuously evolved to meet the most pressing needs of children and teens in our community and beyond.
Dr. Schubert made immeasurable contributions to Cincinnati Children’s as a physician, child advocate, researcher, teacher, mentor and leader.
